Abstract Library

#4577 Diagnosis of a cervical carotid paraganglioma: A case report and review of diagnostic imaging approaches

Introduction: Cervical paragangliomas are rare, often non-secreting tumours of neuroectodermal origin. Their diagnosis can be challenging due to the variability of clinical presentations and the diagnostic tests required.

Conference:

Presenting Author: Otmane R

Authors: Otmane R, Boudersa A, Kouadri N,

Keywords: Paraganglioma, cervical, octreoscan,

#4573 Digestive neuroendocrine tumours: Patterns, pathways, and progress in personalised management

Introduction: Digestive neuroendocrine tumours (NETs), though rare, are increasingly diagnosed with their incidence rising. Histopathological examination is crucial for diagnosis and grading, based on cell differentiation and proliferation index. Often diagnosed late due to non-specific symptoms, these tumours may present with hormone hypersecretion. Updated classifications now allow better risk stratification and tailored treatments. Advances in imaging, particularly PETscans with somatostatin analogues have improved NET diagnosis and monitoring.

Conference:

Presenting Author: Bensetti Houari A

Authors: Bensetti Houari A, Remouche H, Belkharoubi K,

Keywords: Digestive neuroendocrine tumour, octreoscan, multidisciplinary approach,

#4446 Uncommon ophthalmic presentation of a small bowel neuroendocrine tumour: Case report

Introduction: Neuroendocrine tumours (NETs), including carcinoid tumours, are slow-growing neoplasms commonly originating in the gastrointestinal tract or bronchus, but they can also arise in other sites. Due to their indolent nature, the majority of NETs are diagnosed at an advanced stage, typically to the lymph nodes, liver, or bones.

Conference:

Presenting Author:

Authors: Hamidatou K, Behourah Z, Ahed Messaoud M, Megaiz A, Lechar M,

Keywords: Neuroendocrine tumour, Carcinoid tumour, Orbital metastasis, somatostatin analogue injection,

#4042 177Lu-dotatate as salvage therapy in bronchial and GEP NET patients: The IRST "Dino Amadori" experience

Introduction: RLT with SSA represents a treatment of choice after progression from “cold” SSA analogues in NENs. After progression from RLT, other systemic treatments are used including a salvage therapy with RLT that is increasingly proposed.

Conference:

Presenting Author:

Authors: Sansovini M,

Keywords: Neuroendocrine tumor, salvage radioligand therapy,

#3870 Small bowel neuroendocrine tumor with carcinoid heart disease

Introduction: Patients with neuroendocrine tumors are often misdiagnosed, at least for the first stage of the disease. In fact, carcinoid syndrome is the clinical expression of the vasoactive substances produce. Carcinoid heart disease is a hazardous and irreversible complication especially in late identified cases.

Conference:

Presenting Author:

Authors: Aliane H, Ghomari-Bezzar S,

Keywords: Neuroendocrine, Small bowel,